Latest News

Hip Resurfacing Shows Lower Metal Ion Levels and Revision Risk Than Large-Head Metal-on-Metal THA

A recent systematic review and meta-analysis published in JBJS Reviews compared hip resurfacing arthroplasty (HRA) with large-diameter head metal-on-metal total hip arthroplasty (LDH-THA) across 21 studies.

Celebrating One Year of Progress: Polymotion Hip Resurfacing IDE Study

A key milestone in the clinical advancement of next-generation hip preservation technology.

Polymotion IDE Study Achieves 85% Enrolment in 2025

The Polymotion® Hip Resurfacing (PHR®) IDE study is closing out 2025 on a high note, having reached 85% enrolment.

Celebrating Three Years of Polymotion Hip Resurfacing Innovation

Marking a Milestone in Modern Hip Resurfacing

Hip Resurfacing a suitable option for those with mild DDH (Crowe I and II)

Systematic review supports selective use of hip resurfacing arthroplasty in mild DDH

Polymotion IDE Study Passes 60% Enrolment

The Polymotion Hip Resurfacing (PHR®) IDE study has officially passed the 60% enrolment mark, bringing us another step closer to completing this pivotal trial.

Long-Term Survivorship of Hip Resurfacing in Patients under 30

A recent study published in International Orthopaedics (2025) reports the longest follow-up to date on the outcomes of hip resurfacing arthroplasty (HRA) in patients under the age of 30.

Polymotion IDE Hip Resurfacing Study Reaches 100 Surgeries

We’re proud to share that we have successfully completed the 100th surgery in our ongoing U.S. Investigational Device Exemption (IDE) study of the Polymotion® Hip Resurfacing System.

Hip Resurfacing Delivers Comparable Outcomes to THA in Patients 65 and Older

Key findings highlight the growing relevance of HRA as a versatile treatment option for a broader and more diverse aging population

Polymotion IDE Study Reaches 30% Enrolment Milestone

Momentum Builds as Polymotion® Hip Resurfacing IDE Study Reaches 30% Enrolment and Expands to Nine Active Sites

Hip resurfacing arthroplasty reduces dislocation and infection rates...

Latest meta-analysis highlights favourable outcomes

“There is no significant difference in postoperative outcomes between younger and older patients undergoing HRA".

Hip Resurfacing Not Just for the Young: Older Patients Also Experience Favourable Outcomes

JointMedica announces launch of IDE Study for Polymotion Hip Resurfacing System

The IDE study aims to evaluate the safety and clinical effectiveness of the PHR® System to address the challenges faced by younger, more active patients.

Our second site for the IDE Study on the Polymotion Hip Resurfacing device is now live!

Our second site for the IDE Study on the Polymotion® Hip Resurfacing device is now live!

It’s official—we’ve begun our IDE Study for the Polymotion Hip Resurfacing device!

IDE Study Launched for Polymotion® Hip Resurfacing Device

Dr. Werle Performs First Polymotion Hip Resurfacing Case at Rockyview General Hospital, Calgary

A significant milestone in orthopaedic surgery at Rockyview General Hospital in Calgary

Internal Polymotion Hip Resurfacing training for our latest recruits

​

JointMedica Honours Ian Bowen with Inaugural President's Award

JointMedica is proud to announce that Ian Bowen, Manufacturing Engineering Manager, has been awarded the company’s first President's Award.

Commercial Team Delivers Expert Training on Polymotion Hip Resurfacing System in Gainesville

Commercial Team Delivers Expert Training

Student Training Day

Ruby Garner, a Medical Engineering student from Cardiff University, visited us for an immersive training day.

Global Excellence Awards - 2024

JointMedica named the Best Orthopaedic Hip Device Manufacturer 2024 - Midlands!

Mr Ronan Treacy, Travelling Professorship

University of Toronto invited Mr. Ronan Treacy to take part in the prestigious Grand Rounds

Adoption of JointMedica Technologies in Toronto, Canada

First Polymotion Hip Resurfacing (PHR®)* procedure performed in Ontario, Canada

JointMedica Announces Key Leadership Appointments and Organisational Changes.

JointMedica Key Leadership Appointments and Organisational Changes.

JointMedica Announces First Hip Resurfacing Procedures in New Zealand with Polymotion Hip Implant

Dr. Sharat Kusuma, representing JointMedica, journeyed to New Zealand to oversee the first in-patient surgeries featuring the innovative Polymotion® Hip Resurfacing

Avi Pelossof has joined JointMedica

Avi Pelossof Appointed Executive Chairman of JointMedica, Spearheading Innovation in Medical Technology

Hip Resurfacing is recognized as a key milestone in healthcare and technology advancements in the Midlands

The NHS marked 75 years of service. In honour of this, ITVX shared a newsreel featuring key milestones in healthcare and technology advances from the Midlands

Hip resurfacing arthroplasty as an alternative to total hip arthroplasty in patients aged under 40 years

The largest retrospective analysis of hip resurfacing arthroplasty (HRA) specifically for patients aged under 40 years...

More patients returned to running following HRA than THA with lower rates of revision.

Running Following Hip Arthroplasty by Harrington, Colin J et al. 2023

Steve Meakins takes on Tough Mudder

Steve Meakins alongside 39 team members, raised over £15,000 for Ashfield Trust by taking on this years Tough Mudder Challenge.

The Importance of Postoperative Rehabilitation...

Impact loads and strength reach interlimb symmetry at 6 months post- Hip Resurfacing Arthroplasty (HRA).

JointMedica finalists for the National Medilink UK Healthcare Business Awards 2023

National Finalist Medilink UK Health Care Business Award 2023

Resurfacing Hip Arthroplasty Is a Safe and Effective Alternative to Total Hip Arthroplasty in Young Patient

RHA caused significantly lower blood loss and similar satisfactory functional results, with no significant difference in metal ion levels.

HRA patients observed greater stride length and greater range of motion

Resurfacing hip arthroplasty better preserves a normal gait pattern at increasing walking speeds compared to total hip arthroplasty

Trends and developments in hip and knee arthroplasty technology

Hip resurfacing has been highlighted as one of the most interesting trends and developments in the field of arthroplasty.

JointMedica announced as West Midlands Innovation Winners

Winners of the Medilink Midlands Business Awards 2023 announced

JointMedica Manufacturing Expansion Continues

For the final step of last year’s initial expansion phase, JointMedica welcomed the arrival of a second Brother Speedio CNC Machine.

Innovation finalist for the Medilink Midlands Business Awards 2023

JointMedica has been shortlisted for the “Innovation” category which recognises the development of innovative technology.

20 Years of Hip Resurfacing success in Canada

Dr. Jim MacKenzie of Calgary Orthopaedics Celebrates 20 years of Hip Resurfacing

60th anniversary of the “Charnley Hip” a technique that revolutionised modern hip arthroplasty

The 1962 surgery was the first total hip replacement to be performed using low friction prostheses at Wrightington

Increasing number of patients were able to RTS after HRA over the first one year after surgery

A meta-analysis assessing time for return for sport following hip resurfacing

Recent employment of Michelle Evans as Manufacturing Technician.

This is addition to the Manufacturing team and is testament to the continued growth of JointMedica.

HRA has been seen to have lesser associated complications compared to THR

Complications and mid to long term outcomes for hip resurfacing versus total hip replacement: a systematic review and meta-analysis’